BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
Market capitalization of BioXcel Therapeutics (BTAI)
Market cap: $44.28 Million
As of June 2024 BioXcel Therapeutics has a market cap of $44.28 Million. This makes BioXcel Therapeutics the world's 7913th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioXcel Therapeutics from 2018 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $44.28 M | -48.72% |
| 2023 | $86.35 M | -85.65% |
| 2022 | $0.60 B | 5.82% |
| 2021 | $0.56 B | -49.57% |
| 2020 | $1.12 B | 326.88% |
| 2019 | $0.26 B | 337.08% |
| 2018 | $60.46 M |
End of Day market cap according to different sources
On Jun 25th, 2024 the market cap of BioXcel Therapeutics was reported to be:
$44.28 Million
$44.28 Million
$44.28 Million
$45.03 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.45 B | 926.11% | 🇺🇸 USA |